FAKTOR-OPTIONSSCHEIN - DIASORIN Stock

DE000MG1L5C7

Market Closed - Börse Stuttgart 02:21:18 2024-06-13 pm EDT
14.19 ^EUR	+1.21%

Current month	+4.34%
1 month	-0.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Funds move on Mid and Mib bank stocks.	Jun. 13	AN
Funds move on Iveco and initiate short	Jun. 12	AN
Capital Fund raises short on BPER and Telecom Italia	Jun. 11	AN
Mib up at start, DiaSorin good on FDA news	Jun. 05	AN

More news

Quotes 5-day view

Date	Price	Change
24-06-13	14.19	+1.21%
24-06-12	14.02	+3.01%
24-06-11	13.61	-2.02%
24-06-10	13.89	-4.14%
24-06-07	14.49	+2.40%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 02:21 pm EDT

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	Morgan Stanley
WKN	MG1L5C
ISIN	DE000MG1L5C7
Date issued	2024-04-03
Strike	67.11 €
Maturity	Unlimited
Parity	2.38 : 1
Emission price	10 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	15.27 €
Lowest since issue	8.37 €
Spread	0.04 €
Spread %	0.28%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

100.6 EUR

Average target price

101.7 EUR

Spread / Average Target

+1.00%

Consensus